Stay updated with breaking news from Daniel Vasella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Der Ex-Novartis-Chef hat ein dickes Fell. Im Gespräch erklärt er, warum er nach seinem Abschied trotzdem untergetaucht ist, er eine Rezession für nötig hält und Manager mehr über Sex reden müssen.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Ghanaian health tech startup mPharma is building a network of community pharmacies across Africa as it plans to be the go-to primary healthcare service provider for millions of people residing in the region. mPharma plans to grow its community (Mutti) pharmacies across eight markets in Africa to be the first point of care for patients. […]
(Bloomberg) -- Novartis AG agreed to sell its stake in Roche Holding AG back to the rival Swiss drugmaker for $20.7 billion, ending a two-decade investment and building up a cash pile for possible acquisitions. Novartis took advantage of record levels in Roche’s voting stock to unwind the remnants of a failed takeover attempt that began in 2001 under then-Novartis Chief Executive Officer Daniel Vasella. The company is booking a capital gain of about $14 billion on the investment at a time when the cost of acquisitions in pharma have been soaring and drugmakers need funds to develop new treat...